Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 9, 1996, Pages 2087-2093

  Kerb, Reinhold ^a   Brockmöller, Jürgen ^a   Staffeldt, Beate ^a   Ploch, Michael ^a   Roots, Ivar ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERICIN; HYPERICUM EXTRACT; PSEUDOHYPERICIN;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TOLERANCE; HUMAN; HUMAN EXPERIMENT; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEADY STATE;

EID: 0029794744     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.9.2087     Document Type: Article

References (27)

1. Andersen, D. O., N. D. Weber, S. G. Wood, B. G. Hughes, B. K. Murray, and J. A. North. 1991. In vitro activity of selected anthraquinones and anthraquinone derivates. Antivir. Res. 16:185-196.
2. Araya, O. S., and E. J. H. Ford. 1981. An investigation of the type of photosensitization caused by the ingestion of St. John's Wort (hypericum perforatum) by calves. J. Comp. Pathol. 91:135-141.
3. Barnard, D. L., J. H. Huffman, J. L. B. Morris, S. G. Wood, B. G. Hughes, and R. W. Sidwell. 1992. Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus. Antivir. Res. 17:63-77.
4. Brockmann, H. V., and D. Spitzner. 1975. Die Konstitution des Pseudohypericins. Tetrahedron Lett. 24:37-40.
5. Carpenter, S., M. J. Fehr, G. A. Kraus, and J. W. Petrich. 1994. Chemiluminescent activation of the antiviral activity of hypericin: a molecular flashlight. Proc. Natl. Acad. Sci. USA 91:12273-12277.
6. Conolly, K. J., and S. M. Hammer. 1992. Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition. Antimicrob. Agents Chemother. 36:509-520.
7. Degar, S., A. M. Prince, D. Pascual, G. Lavie, B. Levin, Y. Mazur, D. Lavie, L. S. Ehrlich, C. Carter, and D. Meruelo. 1992. Inactivation of the human immunodeficiency virus by hypericin: evidence for photochemical alterations of p24 and a block in uncoating. AIDS Res. Hum. Retroviruses 8:1929-1936.
8. Derendorf, H., and E. R. Garret. 1987. Pharmakokinetik. Wissenschaftliche Verlags-Gesellschaft, Stuttgart.
9. Diwu, Z. 1995. Novel therapeutic and diagnostic applications of hypocrellins and hypericins. Photochem. Photobiol. 61:529-539.
10. Freytag, W. E. 1984. Bestimmung von Hypericin und Nachweis von Pseudohypericin in Hypericum perforatum L. durch HPLC. Dtsch. Apoth. Ztg. 123:2383-2386.
11. Gabrielsson, J., and D. Weiner. 1994. Pharmacokinetic/pharmacodynamic data analysis: concepts and applications. Swedish Pharmaceutical Press, Stockholm.
12. Giese, A. C. 1980. Hypericism. Photochem. Photobiol. Rev. 5:229-255.
13. Harrer, G., and H. Sommer. 1994. Treatment of mild/moderate depressions with Hypericum Phytomed. 1:3-8.
14. Hudson, J. B., L. Harris, and G. H. Towers. 1993. The importance of light in the anti-HIV effect of hypericin. Antiviral Res. 20:173-8.
15. Kerb, R., T. Reum, J. Brockmöller, S. Bauer, and I. Roots. 1995. No clinically relevant photosensitization after single-dose and steady state iv treatment with hypericum extract in man. Eur. J. Clin. Pharmacol. 49:A156.
16. Lavie, G., Y. Mazur, D. Lavie, A. M. Prince, D. Pascual, L. Liebes, B. Levin, and D. Meruelo. 1995. Hypericin as an inactivator of infectious viruses in blood components. Transfusion 35:392-400.
17. Lavie, G., F. Valentine, B. Levin, Y. Mazur, G. Gallo, D. Lavie, D. Weiner, and D. Meruelo. 1989. Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin. Proc. Natl. Acad. Sci. USA 86:5963-5967.
18. Lenard, J., A. Rabson, and R. Vanderoef. 1993. Photodynamic inactivation of infectivity of human immunodificiency virus and other enveloped viruses using hypericin and rose bengal: inhibition of fusion and syneytia formation. Proc. Natl. Acad. Sci. USA 90:158-162.
19. Liebes, L., Y. Mazur, D. Freeman, D. Lavie, G. Lavie, N. Kudler, S. Mendoza, B. Levin, H. Hochster, and D. Meruelo. 1991. A method for the quantification of hypericin, an antiviral agent, in biological fluids by high-performance liquid chromatography. Anal. Biochem. 195:77-85.
20. Meruelo, D., G. Lavie, and D. Lavie. 1988. Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc. Natl. Acad. Sci. USA 85:5230-5234.
21. Mueller, E. A., J. M. Kovarik, J. B. Van Bree, A. E. Lison, and K. Kutz. 1994. Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients - a concentration-controlled comparison with the commercial formulation. Transplantation 57:1178-1182.
22. Rowland, M., and T. N. Tozer. 1989. Clinical pharmacokinetics: concepts and applications, 2nd ed. Lea & Febiger, Philadelphia.
23. Schwabe, U., and D. Paffrath. 1995. Arzneiverordnungs-Report '95: aktuelle Daten, Kosten, Trends und Kommentare, p. 375. Gustav Fischer Verlag, Stuttgart.
24. Senthil, V., J. W. Longworth, C. A. Ghiron, and L. I. Grossweiner. 1992. Photosensitization of aqueous model systems by hypericin. Biochim. Biophys. Acta 1115:192-200.
25. Staffeldt, B., R. Kerb, J. Brockmöller, M. Ploch, and I. Roots. 1994. Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers. J. Geriatr. Psychiatry Neurol. 7(Suppl. 1):47-53.
26. Yenning, G. R., and M. S. Scott. 1992. New drug treatments for HIV infection and AIDS: a review following the 7th International Conference on AIDS, Florence, 16 to 21 June 1991. Br. J. Clin. Pharmacol. 33:349-356.
27. Weber, N. D., B. K. Murray, J. A. North, and S. G. Wood. 1994. The antiviral agent hypericin has in vitro activity against HSV-1 through non-specific association with viral and cellular membranes. Antiviral Chem. Chemother. 5:83-90.